Ainnocence Calls for Collaboration to Deploy AI-Driven Antibody Discovery Against World’s Deadliest Infectious Diseases
A Study shows mutation-resistant antibodies with 269×affinity, a proof point for CEPI’s 100 Days Mission and closing the therapeutic gap for 2.5B people at risk SAN FRANCISCO , CA, UNITED STATES, March 6, 2026 /EINPresswire.com/ -- Ainnocence Inc., a …